Literature DB >> 16595930

Anti-complementary activity of ursane-type triterpenoids from Weigela subsessilis.

Phuong Thien Thuong1, Byung-Sun Min, WenYi Jin, MinKyun Na, JongPill Lee, RackSeon Seong, Young-Mi Lee, KyungSik Song, YeonHee Seong, Hyeong-Kyu Lee, KiHwan Bae, Sam Sik Kang.   

Abstract

A new ursane-type triterpenoid, weigelic acid (1), and seven known compounds, ursolic acid (2), ilekudinol A (3), corosolic acid (4), ilekudinol B (5), esculentic acid (6), pomolic acid (7), and asiatic acid (8) were isolated from the leaf and stem of Weigela subsessilis. The structure of the new triterpenoid was established as 1beta,2alpha,3alpha,23-tetrahydroxyurs-12-en-28-oic acid on the basis of spectroscopic analyses. In addition, the isolated compounds were evaluated for their anti-complement activity against the classical pathway of the complement system. Of these, compounds 1-2 and 4-8 exhibited anti-complement activity with IC50 values of 152, 90, 130, 51, 56, 4, and 163 microM, respectively, whereas 3 was inactive. This shows that a carboxylic group of ursane-type triterpenoids seems to play an important role in inhibiting the hemolytic activity of human serum against erythrocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16595930     DOI: 10.1248/bpb.29.830

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  4 in total

Review 1.  Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise.

Authors:  Mohamed Fizur Nagoor Meeran; Sameer N Goyal; Kapil Suchal; Charu Sharma; Chandragouda R Patil; Shreesh K Ojha
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

Review 2.  Antimicrobial activity of oleanolic and ursolic acids: an update.

Authors:  Jéssica A Jesus; João Henrique G Lago; Márcia D Laurenti; Eduardo S Yamamoto; Luiz Felipe D Passero
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-22       Impact factor: 2.629

3.  Management of Diabetes and Its Complications with Banaba (Lagerstroemia speciosa L.) and Corosolic Acid.

Authors:  Toshihiro Miura; Satoshi Takagi; Torao Ishida
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-02       Impact factor: 2.629

4.  Corosolic acid reduces 5‑FU chemoresistance in human gastric cancer cells by activating AMPK.

Authors:  Jun Beom Park; Jin Sun Lee; Myung Sun Lee; Eun Young Cha; Soyeon Kim; Ji Young Sul
Journal:  Mol Med Rep       Date:  2018-07-03       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.